No matter how much technology we have at our disposal, it’s still a human-to-human interaction. That’s what I never want to lose track of.
As a physician you have to be open to learning from patients because everybody experiences their illness differently.
Should you encourage your child to become a single-sport athlete? A sports medicine specialist weighs in.
Many foods not widely known for wholesomeness actually have a lot to offer, nutrient-wise.
Pre-Menopausal Heavy Uterine Bleeding and Uterine Fibroids Study
Clinical Trial Title:
Study for pre-menopausal women with heavy uterine bleeding and uterine fibroids
Clinical Trial Protocol ID:
11081503
Clinical Trial Investigator Name:
Barbara Soltes, MD
Clinical Trial Protocol Description:
The purpose of this study is to determine the efficacy of an oral investigational medication to decrease frequency and amount of uterine bleeding as well as size or volume of uterine fibroids.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Have a diagnosis of uterine fibroids.
- Have heavy uterine bleeding during menstrual cycles.
- Are a pre-menopausal women 20 years of age or older.
You will be excluded from the study if any of the following criteria apply to you:
- Have endometriosis.
- Have osteoporosis.
- Are currently using any corticosteroid.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.
Clinical Trial Area:
Women's Health
Contact Phone:
(312) 563-2611
Contact Name:
Carol Miller